Nonoperative management of rectal cancer: Current perspectives

Clinical Colorectal Cancer

Volumn 9, Issue 2, 2010, Pages 83-88

  Higgins, Kristin ^a   Willett, Christopher ^a   Czito, Brian ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoradiation; Clinical regression; Contact radiotherapy; Radiotherapy; Surgical resection; Unresectable

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; IRIDIUM 192; OXALIPLATIN;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL RECTAL EXAMINATION; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PROCTITIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECTOSCOPY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM CARCINOMA; REVIEW; SALVAGE THERAPY; THORAX RADIOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR BIOPSY;

EID: 77950799423     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2010.n.011     Document Type: Review

References (40)

1. Kapiteijn EM, Marijnen CM, Nagtegaal ID. Preooperative radiotherapy combined with total mesorectal Excision for resectable rectal cancer. N Engl J Med 2001; 345:638-646
2. Saurer RB, Becker H, Hohenberger W. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731-1740 (Pubitemid 39383208)
3. Folkesson JB, Birgisson H, Pahlman L. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23:5644-5650 (Pubitemid 46300160)
4. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355:1114-1123 (Pubitemid 44394918)
5. Gérard J, Conroy T, Bonnetain F, et al. Preoperative radiatiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24:4620-4625 (Pubitemid 46630960)
6. Chau IB, Brown G, Cunningham D. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in Magnetic Resonance Imaging-Defined Poor Risk Rectal Cancer. J Clin Oncol 2006; 24:668-674 (Pubitemid 46630432)
7. Habr-Gama AP, Perez RO, Nadalin W. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy. Ann Surg 2004; 240:711-718 (Pubitemid 39281293)
8. Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008; 72:99-107.
9. Habr-Gama A. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Dis 2006; 8(suppl 3):21-24
10. Lim L, Chao M, Shapiro J, et al. Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Dis Colon Rectum 2007; 50:2032-2039 (Pubitemid 350275863)
11. Moore HG, Gittleman AE, Minsky BD. Rate of pathologic complete response with increased interval between preoperative combine modality therapy and rectal cancer resection. Dis Colon Rectum 2004; 47:279-286 (Pubitemid 38280578)
12. Tulchinsky HS, Shmueli E, Figer A. An interval > 7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 2008; 15:2661-2667
13. Francois Y, Nemoz C, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincertsparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17:2396. (Pubitemid 29368238)
14. Wang Y, Cummings B, Catton P, et al. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother Oncol 2005; 77:126-132 (Pubitemid 41682376)
15. Deniaud-Alexandre ET, Touboul E, Tiret E. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003; 56:1259-1273 (Pubitemid 36842877)
16. Cummings B, Keane T, O'Sullivan B, et al. Treatment of radiation alone or by radiation and 5-fluorouracil with and without mitomycin-C. Int J Radiat Oncol Biol Phys 1993; 21:1115.
17. Papillon J. Present status of radiation therapy in the conservative management of rectal cancer. Radiother Oncol 1989; 17:275-283
18. Gerard J, Romestaing P, Chapet O. Radiotherapy alone in the curative treatment of rectal carcinoma. Lancet Oncol 2003; 4:158-166 (Pubitemid 36322306)
19. Gerard J, Ayzac L, Coquard R, et al. Endocavitary irradiation for early rectal carcinomas T1(T2). A series of 101 patients treated with the Papillon's technique. Int J Radiat Oncol Biol Phys 1996; 34:775-783 (Pubitemid 26089214)
20. Aumock AB, Birnbaum EH, Fleshman JW. Treatment of rectal adenocarcinoma with endocavitary and external beam radiotherapy: results for 199 patients with localized tumors. Int J Radiat Oncol Biol Phys 2001; 51:363-370
21. Gerard JP, Chapet O, Nemoz C. Improved sphincter preservaton in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol 2004; 22:2404-2409 (Pubitemid 41115397)
22. Greenberg JA, Shibata D, Herndon JE. Local excision of distal rectal cancer: an update of Cancer and Leukemia Group B 8984. Dis Colon Rectum 2008; 51:1185-1194
23. Lindegaard J, Gerard J, Sun M, et al. Whither Papillon? Further directions for contact radiotherapy in rectal cancer. Clin Oncol (R Coll Radiol) 2007; 19:738-741
24. Guillem J, Chessin D, Shia J, et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol 2005; 23:20.
25. Kristiansen CL, Loft A, Berthelsen A. PET/CT and histopatologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum 2007; 51:21-25
26. Guillem JG, Puig-La Calle J Jr, Akhurst T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000; 43:18-24.
27. Kim IL, Lim SB, Kang HC. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 2007; 50:1342-1353
28. Rödel C, Martus P, Papadoupolous T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23:8688-8696
29. Habr-Gama AP, Proscurshim I. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 2008; 71:1181-1188
30. Habr-Gama AP, Perez RO, Proscurshim I. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10:1328-1329 (Pubitemid 44908999)
31. O'Neill BD, Brown G, Heald RJ et al. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007; 8:625-633 (Pubitemid 47008889)
32. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310-2317 (Pubitemid 46218723)
33. Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25:1160-1168 (Pubitemid 46640561)
34. Cooper J, Guo M, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 28:1623-1627 (Pubitemid 29211772)
35. Foote R, Foote R, Brown P, et al. Organ preservation for advanced laryngeal carcinoma. Head Neck 2006; 28:689-696 (Pubitemid 44116893)
36. Fisher B, Anderson S, Redmond C, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333:1456-1461
37. Sischy B, Graney MJ, Hinson EJ. Endocavitary irradiation for adenocarcinoma of the rectum. CA Cancer J Clin 1984;34:333-339 (Pubitemid 15195947)
38. Maingon PG, Guerif S, Sarsouni R. Conservative management of rectal adenocarcinoma by radiotherapy. Int J Radiat Oncol Biol Phys 1998; 15:1077-1085 (Pubitemid 28152922)
39. Myint AG, Grieve RJ, McDonald AC. Combined modality treatment of early rectal cancer: the UK experience. Clin Oncol 2007; 19:674-681 (Pubitemid 47471504)
40. Rauch PB, Bey P, Peiffert D. Factors affecting local control and survival after treatment of carcinoma of the rectum by endocavitary radiation: a retrospective study of 97 cases. Int J Radiat Oncol Biol Phys 2001; 49:117-124 (Pubitemid 32041283)